Navigation Links
Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
Date:1/7/2008

promote insulin release by beta cells in response to elevated blood glucose levels. In addition, in preclinical studies, the GDIR stimulates the release of GLP and GIP, two incretins that are important for proper insulin regulation, which may enhance glucose homeostasis. GDIR stimulation has also been found to increase the levels and activity of intracellular factors thought to be involved in the preservation of beta cells. The GDIR is amenable to small molecule, orally active, drug development.

About Diabetes

Diabetes is a major worldwide disease. Based on 2003 data, the International Diabetes Federation estimated that in 2005 there were 194 million adults with diabetes worldwide, an increase of over 40% since 1995. Approximately 90%, or 175 million, of diabetics worldwide suffer from type 2 diabetes, the adult-onset form of the disease. Type 2 diabetes is characterized by inadequate response to insulin or inadequate secretion of insulin as blood glucose levels rise. Therapies for type 2 diabetes are directed toward correcting the body's inadequate response with oral or injectable medications, or directly modifying insulin levels by injection of insulin or insulin analogs. The worldwide market for diabetes medications exceeded $10 billion in 2004, of which oral drugs exceeded $6 billion.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
2. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
3. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
4. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
5. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
6. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
7. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
8. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
9. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
10. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
11. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015  Geneia, a company of experienced ... to improve healthcare efficiencies, today announced a first-of-its-kind ... (BNRC) use Geneia,s advanced analytics solution coupled ... quality and lower the cost of patient care. ... claims and utilization data from multiple sources to ...
(Date:5/4/2015)... 4, 2015 The Pharmacy Workforce Center recently ... that pharmacy has shifted toward a female-dominated profession. With ... managers, there is an incredible opportunity for women to ... decade. In a new blog post ... Insights , Eden Sulzer, director of the Women ...
(Date:5/4/2015)... May 4, 2015 Eli Lilly and ... reports that provide a comprehensive overview of the ... Lilly is evolving its approach to corporate responsibility ... partnership with others to have greater, more sustainable ... Update offers a thorough look at the ...
Breaking Medicine Technology:Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 3Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 2Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 3Lilly Releases Corporate Responsibility, Global Health Reports 2Lilly Releases Corporate Responsibility, Global Health Reports 3Lilly Releases Corporate Responsibility, Global Health Reports 4
... of Echocardiography,s Scientific Sessions , , ... Echocardiography (ASE) welcomes the world,s leading researchers in cardiovascular ... Annual Scientific Sessions, June 6-10, at the Gaylord National ... basketball player and former heart patient, Ronny Turiaf will ...
... and Efficacy with Once-Daily, 200 milligrams (mg) Dosing over ... , SAN DIEGO, June 8 Trius Therapeutics, Inc. ... evaluating the safety and efficacy of oral torezolid (TR-701), ... skin and skin structure infections (cSSSI) caused by gram-positive ...
Cached Medicine Technology:New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients 2New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients 3New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients 4Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 2Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 3Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 4
(Date:5/4/2015)... The University of California, Davis and ... initiative at UC Davis School of Medicine dedicated ... to advancing Latino health. , The program, called ... to Be Physicians, (“Prep Médico” for short) is ... and internship opportunities, a residential program, intensive language ...
(Date:5/4/2015)... 2015 Getting patients to work with ... is critical to achieving the “triple aim” of better ... this will require a shift in thinking from stakeholders ... health systems move beyond their traditional boundaries to reach ... the third live meeting of the ACO and ...
(Date:5/4/2015)... The American Telemedicine Association (ATA) today released an ... gaps in coverage and reimbursement, and physician practice standards ... Gaps Reports last September, many state regulating bodies responded ... healthcare delivery in their state,” said Jonathan Linkous, CEO ... the nation, ATA reevaluated the indicators for each state ...
(Date:5/4/2015)... 04, 2015 The U.S. healthcare worker ... join the ranks of senior citizens (1) and 27 ... already over-burdened healthcare system. Additionally, as older healthcare employees ... them. Per the U.S. Census Bureau, the number of ... 75% by 2050 while those 25 to 54 will ...
(Date:5/4/2015)... May 04, 2015 Los Angeles ... offering a more comfortable and attractive alternative for patients ... choice for those who have lost teeth. Unfortunately, they ... insecure or slip at the worst possible moment and ... talks. They can also painfully pinch or rub gums, ...
Breaking Medicine News(10 mins):Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 3Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 4Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 5Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 4Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2
... common BP medication during first trimester of pregnancy have ... The Food and Drug Administration reports from data collected ... ,The study, led by William Cooper, M.D., M.P.H., associate ... Hospital at Vanderbilt, found infants born to mothers who ...
... develooped to assess the risk of heart disease in British ... // ,ETHRISK is for everyday use in the ... developed by researchers at the University of Bristol to improve ... and minority ethnic groups. ,Ethnic groups within Britain have a ...
... patients' groups told MSPs that charging patients and their ... ,They also voiced their concerns about increasing ... because of centralisation of hospital services. ,Patients ... day for parking in certain parts of the country. ...
... enzymes interact physically in a biochemical partnership as well ... ,The study was conducted by researchers at ... University, Ontario, Canada and reported in the online edition ... for their contrasting role in cardiovascular biology.,Collaborators Garret FitzGerald, ...
... chances of surviving a heart attack has improved the odds ... ,The Canadian Institute for Health Information in its annual report ... a new heart attack fell to 11.1 per cent in ... case of strokes, 18.8 per cent of stroke patients admitted ...
... a recent study conducted by the Canadian researchers it was ... their likelihood to land in emergency care//. , ... people are trained in a similar way as those specially ... to the emergency care by 50%. Dr. Mark Loeb, a ...
Cached Medicine News:Health News:Birth Defects Link With ACE Inhibitor Use, FDA Reports 2Health News:New Web- Based Calculator to Assess Heart Disease Risk 2Health News:New Role of COX Enzymes Discovered 2Health News:Survival Rates of Heart Attack Improving 2
... Monitoring Lumen., ,Designed for neonatal and ... incorporates a monitoring lumen within the wall ... distal tip. Luer lock connector bonded to ... monitoring, pressure monitoring or syringe irrigation of ...
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes...
Nasal soft cuffed endotracheal tubes designed and constructed especially for long-term nasal intubations....
Pediatric Tracheal Tubes with Micro-thin-walled cuffs....
Medicine Products: